S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

QLGN Qualigen Therapeutics Inc

4.28

0.11 (2.64%)

After Hours

Last Updated: 08:35:00

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Qualigen Therapeutics (NASDAQ:QLGN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Qualigen Therapeutics Charts.

Qualigen Therapeutics (NASDAQ:QLGN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Qualigen Therapeutics Charts.

Qualigen Therapeutics Inc News

Form 8-K - Current report
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Friday 20 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
Friday 6 December 2024 (1 month ago) • GlobeNewswire Inc.

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
Tuesday 26 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Wednesday 20 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 2 November 2024 (2 months ago) • Edgar (US Regulatory)

More Qualigen Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions